Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: New therapeutic opportunities

Keyphrases

• Dysregulation 100%
• Nuclear factor-B 100%
• New Therapeutics 100%
• Therapeutic Potential 100%
• Splenic Marginal Zone Lymphoma 100%
• TLR Signaling 50%
• Genetic Changes 50%

Medicine and Dentistry

• Nuclear Factor 100%
• Alternative Complement Pathway C3 C5 Convertase 100%
• Splenic Marginal Zone Lymphoma 100%
• Signal Transduction 50%
• Gene Mutation 50%
• TLR Signaling 50%